The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Working-age Americans who get health insurance through their job will see largest health insurance rate hikes since 2010.

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...

Eli Lilly and Company (NYSE: LLY) will participate in the Bernstein's 2nd Annual Healthcare Forum on September 25, 2025.

Big Pharma faces tariff risks, patent cliffs, and regulatory pressure, but innovation and strong pipelines keep Eli Lilly, ...

Novo Nordisk A/S’s new chief executive officer is calling workers back to the office as the Ozempic maker struggles to catch ...

Takeda names Rhonda Pacheco as U.S. Business Unit President, bringing expertise from Eli Lilly. Read more here.

Eli Lilly’s new obesity drug could change how millions approach weight loss. Appeals court finds Florida's open carry ban ...

Susan J. Schniepp, Distinguished Fellow, Regulatory Compliance Associates, joins PDA CEO Glenn Wright and Melissa Seymour, ...

The deal includes AI-powered software for detecting known side effects of recently launched Alzheimer’s drugs.

Novo Nordisk, the Danish pharmaceutical company known for its weight-loss drug Wegovy and diabetes medicine Ozempic, has ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...